VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MMCMarsh & McLennan Companies, Inc.
$174.06$85.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksMMCFinancials

Marsh & McLennan Companies, Inc. (MMC) Financials

30Y historyFree accessUpdated daily

MMC has maintained strong operational momentum, evidenced by quarterly revenue reaching $6.4 billion in 2025Q3 and a resilient combined ratio that has fluctuated between 70.3% and 81.6% over the last ten quarters.

MMC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96Dec'95
Revenue26.45B24.46B22.74B20.72B19.82B17.22B16.65B14.95B14.02B13.21B12.89B12.95B12.26B11.92B11.53B10.55B9.83B10.73B11.18B11.92B11.65B11.76B11.59B10.44B9.87B10.31B9.16B7.19B6.01B4.4B3.94B
Revenue Growth %10.47%7.57%9.73%4.54%15.07%3.44%11.38%6.6%6.15%2.47%-0.45%5.63%2.83%3.45%9.25%7.31%-8.38%-4%-6.24%2.31%-0.93%1.49%11%5.79%-4.26%12.57%27.36%19.65%36.44%11.85%14.62%
Medical Costs & Claims15.27B14B13.1B12.07B11.43B10.13B9.73B8.61B8.09B7.69B7.33B7.51B7.23B7.13B6.97B6.46B0007.11B3.81B3.49B9.09B8.17B7.93B8.13B7.26B5.5B5.01B3.55B3.11B
Medical Cost Ratio %57.72%57.22%57.61%58.26%57.64%58.81%58.46%57.56%57.65%58.24%56.88%58.03%58.93%59.83%60.46%61.28%0%0%0%59.67%32.71%29.64%78.46%78.22%80.37%78.88%79.27%76.47%83.41%80.59%78.92%
Gross Profit11.18B10.46B9.64B8.65B8.39B7.09B6.92B6.34B5.94B5.52B5.56B5.44B5.04B4.79B4.56B4.08B9.83B10.73B11.18B4.81B7.84B8.28B2.5B2.27B1.94B2.18B1.9B1.69B997M855M830M
Gross Margin %42.28%42.78%42.39%41.74%42.36%41.19%41.54%42.44%42.35%41.76%43.12%41.97%41.07%40.17%39.54%38.72%100%100%100%40.33%67.29%70.36%21.54%21.78%19.63%21.12%20.73%23.53%16.59%19.41%21.08%
Gross Profit Growth %-8.56%11.42%3.03%18.32%2.56%9.03%6.84%7.65%-0.76%2.26%7.96%5.11%5.11%11.55%-58.45%-8.38%-4%132.47%-38.68%-5.24%231.53%9.76%17.4%-11.02%14.7%12.17%69.71%16.61%3.01%4.94%
Operating Expenses5.04B4.64B4.36B4.37B4.08B4.03B4.24B3.58B3.28B3.09B3.14B3.13B2.96B2.96B2.92B3.15B9.05B10.05B10.33B3.35B6.99B7.67B00174M-2M431M272M199M140M135.1M
OpEx / Revenue %19.05%18.99%19.15%21.09%20.6%23.39%25.47%23.97%23.42%23.36%24.35%24.21%24.13%24.83%25.33%29.82%92.09%93.67%92.43%28.1%59.95%65.26%0%0%1.76%-0.02%4.71%3.78%3.31%3.18%3.43%
Depreciation & Amortization883M746M713M719M747M741M647M494M481M438M423M388M358M349M332M357M365M404M442M488M490M456M391M359M520M488M431M272M199M140M135.1M
Combined Ratio %76.77%76.22%76.77%79.34%78.24%82.2%83.92%81.53%81.07%81.6%81.24%82.23%83.06%84.66%85.79%91.1%92.09%93.67%92.43%87.77%92.65%94.9%78.46%78.22%82.14%78.86%83.98%80.25%86.72%83.76%82.35%
Operating Income6.15B5.82B5.28B4.28B4.31B3.07B2.68B2.76B2.65B2.43B2.42B2.3B2.08B1.83B1.64B939M778M679M846M948M590M600M2.5B2.27B1.76B2.18B1.47B1.42B798M715M694.9M
Operating Margin %23.23%23.78%23.23%20.66%21.76%17.8%16.08%18.47%18.93%18.4%18.76%17.77%16.94%15.34%14.21%8.9%7.91%6.33%7.57%7.95%5.06%5.1%21.54%21.78%17.86%21.14%16.02%19.75%13.28%16.24%17.65%
Operating Income Growth %-10.13%23.41%-0.74%40.64%14.53%-3.04%3.99%9.21%0.5%5.13%10.78%13.56%11.66%74.44%20.69%14.58%-19.74%-10.76%60.68%-1.67%-75.96%9.76%28.98%-19.09%48.53%3.31%77.94%11.61%2.89%3.67%
EBITDA7.03B6.56B6B5B5.06B3.81B3.32B3.25B3.14B2.87B2.84B2.69B2.44B2.18B1.97B1.3B1.14B1.08B1.29B1.44B1.08B1.06B2.89B2.63B2.28B2.67B1.9B1.69B997M855M830M
EBITDA Margin %26.57%26.83%26.37%24.13%25.52%22.1%19.96%21.77%22.36%21.72%22.04%20.76%19.86%18.27%17.09%12.28%11.63%10.09%11.52%12.05%9.27%8.98%24.91%25.22%23.13%25.87%20.73%23.53%16.59%19.41%21.08%
Interest Expense956M700M578M469M444M515M524M290M237M189M163M165M167M181M199M233M241M220M0000000000000
Non-Operating Income-302M-363M-322M-271M-340M-242M-286M227M-225M-238M-51M79M-63M-48M35M-63M-15M-35M0000000000000
Pretax Income5.49B5.48B5.03B4.08B4.21B2.79B2.44B2.24B2.64B2.48B2.31B2.06B1.97B1.7B1.4B769M552M494M847M1.22B571M402M2.33B2.13B1.59B1.96B1.25B1.3B715M668M649.8M
Pretax Margin %20.76%22.41%22.11%19.7%21.23%16.22%14.65%15.01%18.85%18.77%17.89%15.88%16.09%14.22%12.18%7.29%5.61%4.6%7.58%10.23%4.9%3.42%20.15%20.43%16.11%18.97%13.65%18.15%11.9%15.17%16.5%
Income Tax1.29B1.36B1.22B995M1.03B747M666M574M1.13B685M671M586M594M492M422M204M21M113M295M388M192M240M770M747M599M753M524M509M281M209M246.9M
Effective Tax Rate %23.51%24.87%24.35%24.38%24.57%26.75%27.31%25.58%42.87%27.62%29.09%28.49%30.11%29.01%30.06%26.53%3.8%22.87%34.83%31.83%33.63%59.7%32.98%35.02%37.67%38.52%41.92%39%39.3%31.29%38%
Net Income4.13B4.06B3.76B3.05B3.14B2.02B1.74B1.65B1.49B1.77B1.6B1.47B1.36B1.18B993M855M227M-73M2.48B990M404M376M1.54B1.36B974M1.18B726M796M434M459M402.9M
Net Margin %15.6%16.6%16.52%14.72%15.86%11.7%10.46%11.04%10.64%13.38%12.4%11.31%11.07%9.86%8.62%8.1%2.31%-0.68%22.14%8.3%3.47%3.2%13.29%13.07%9.87%11.46%7.93%11.07%7.22%10.42%10.23%
Net Income Growth %2.46%8.09%23.15%-2.96%55.9%15.73%5.58%10.59%-15.61%10.57%9.15%7.96%15.39%18.43%16.14%276.65%410.96%-102.95%150%145.05%7.45%-75.58%12.82%40.14%-17.53%62.67%-8.79%83.41%-5.45%13.92%8.45%
EPS (Diluted)8.358.187.536.046.133.943.413.232.873.372.982.652.432.131.801.570.46-0.144.531.780.740.332.812.451.702.081.331.510.801.040.91
EPS Growth %2.71%8.63%24.67%-1.47%55.58%15.54%5.57%12.54%-14.84%13.09%12.45%9.05%14.08%18.33%14.65%241.3%428.57%-103.09%154.49%140.54%124.24%-88.26%14.69%44.12%-18.27%56.39%-11.92%88.75%-23.08%14.29%8.33%
EPS (Basic)-8.257.606.116.203.983.443.262.913.413.012.692.472.161.831.580.46-0.144.591.800.750.332.892.521.772.171.381.550.811.060.92
Diluted Shares Outstanding494M496M499M505M513M512M511M511M519M524M536M553M558M552M551M544M524M515M546M557M543M535M548M557M572.94M568M544M528M501.73M441.35M442.75M

Key Metrics

Growth RegimeExpanding
ProfitabilityStrong
Balance SheetHealthy
Cash FlowRobust
Top Statement Risk

Wage inflation margin compression

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2025Q3)

Sustained Revenue Momentum Amid Cycles

As reported in recent financial filings, MMC has maintained a consistent growth trajectory, with quarterly revenue reaching $6.4 billion in 2025Q3, reflecting an 11.5% year-over-year increase that underscores the firm's ability to capture value from the ongoing hard insurance market cycle and high client retention rates.

The firm's ability to consistently grow top-line revenue suggests that its brokerage operations are effectively leveraging rising premium rates. Investors should monitor whether this growth remains sustainable if the current hard market conditions begin to soften or if client demand for consulting services faces cyclical headwinds.

Underwriting Efficiency and Margin Resilience

Based on the provided income statement data, MMC has demonstrated robust underwriting discipline, with the combined ratio fluctuating between 70.3% and 81.6% over the last ten quarters, indicating that the firm maintains a significant buffer against operational volatility while effectively managing its core brokerage cost structure.

The stability of the combined ratio suggests that MMC is successfully balancing its high-variable compensation costs against commission-based revenue growth. This performance appears to indicate that the firm's shared services platform is providing meaningful operating leverage, though investors should remain cautious regarding potential wage inflation impacts on future margins.

Operating Scale and Efficiency Drivers

According to historical performance metrics, MMC's operating income has shown significant resilience, peaking at $2.0 billion in 2025Q1, which suggests that the firm's global scale allows for efficient absorption of professional services costs despite the inherent labor-intensive nature of its consulting and brokerage business models.

The firm's ability to scale operating income alongside revenue growth implies that its integration of acquired entities is yielding the expected synergies. However, the reliance on human capital suggests that any disruption in talent retention or a spike in compensation costs could quickly erode these operating efficiencies.

Sensitivity to Macroeconomic Policy Shifts

While MMC's recent earnings have been bolstered by favorable interest rate environments, the lack of explicit investment income disclosure in the provided data warrants further investigation into whether current profitability levels are overly dependent on transient fiduciary interest income rather than core organic brokerage growth.

The firm's reliance on interest earned on premiums held in transit may mask underlying weaknesses in organic growth if interest rates were to decline. Analysts should consider whether the current valuation adequately prices in the risk of a reversal in these high-margin, non-operating revenue streams.

MMC — Frequently Asked Questions

Quick answers to the most common questions about buying MMC stock.

What was Marsh & McLennan Companies, Inc.'s (MMC) revenue in 2024?

For fiscal year 2024, Marsh & McLennan Companies, Inc. (MMC) reported total revenue of $24.46B. This represents a 521.2% increase compared to $3.94B in 1995.

Is Marsh & McLennan Companies, Inc. (MMC) profitable?

Marsh & McLennan Companies, Inc. (MMC) is profitable, generating $4.06B in net income for the fiscal year ending 2024 with a net profit margin of 16.6%.

What is Marsh & McLennan Companies, Inc.'s operating profit margin?

Marsh & McLennan Companies, Inc. (MMC) reported an operating income of $5.82B, resulting in an operating profit margin of 23.8%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Marsh & McLennan Companies, Inc.'s gross profit and gross margin?

Marsh & McLennan Companies, Inc. (MMC) generated $10.46B in gross profit for the year, representing a gross profit margin of 42.8%. This demonstrates the company's core pricing power and production efficiency.